CSHL Assistant Professor Mikala Egeblad, Ph.D. - Cancer Public Lecture

TL;DR

Dr. Mikala Egeblad discusses innovative breast cancer research methods.

Transcript

Cold Spring Harbor laboratory is a National Cancer Institute designated cancer center and we have been so for past 25 years over fifty percent of the research at Cold Spring Harbor Laboratory is focused on cancer research and in addition to breast cancer we're working on a large number of other cancers including brain cancer pancreatic cancer leuke... Read More

Key Insights

• Cold Spring Harbor Laboratory is a leading cancer research center, focusing on various types of cancer including breast cancer, with significant global impact.
• Dr. Mikala Egeblad's research uses imaging techniques to study the interaction between the immune system and breast cancer tumors in real-time.
• The research highlights challenges in drug delivery to tumors, showing that some areas receive insufficient drug concentrations, impacting treatment efficacy.
• Inflammatory cells play a dual role in cancer, potentially aiding tumor growth and metastasis, but could be manipulated to target cancer cells.
• Innovative imaging techniques involve fluorescent labeling to observe live interactions between cancer cells and immune cells in mice.
• Research suggests that altering immune cell behavior could enhance the effectiveness of existing cancer treatments by preventing tumor growth and metastasis.
• Dr. Egeblad's work emphasizes the importance of basic research and community support in advancing cancer research and securing funding.
• Future research aims to harness immune cells' ability to target and destroy cancer cells, with some approaches already in clinical trials.

Questions & Answers

Q: What is the focus of Dr. Mikala Egeblad's research?

Dr. Mikala Egeblad's research focuses on understanding the interaction between the immune system and breast cancer tumors using imaging-based approaches. Her work aims to uncover how chemotherapeutics impact these interactions and to identify new ways to enhance the effectiveness of cancer treatments by manipulating immune cell behavior.

Q: How does Dr. Egeblad's team study cancer cells and immune interactions?

Dr. Egeblad's team uses advanced imaging techniques that involve fluorescent labeling to observe live interactions between cancer cells and immune cells in mice. This approach allows them to see how drugs are distributed within tumors in real-time and to study the behavior of immune cells in response to cancer and treatment.

Q: What challenges in cancer treatment does Dr. Egeblad's research address?

The research addresses challenges in drug delivery to tumors, where some areas receive insufficient drug concentrations, leading to ineffective treatment. It also explores the role of inflammatory cells, which can support tumor growth and metastasis, but could be redirected to attack cancer cells, potentially improving treatment outcomes.

Q: What role do inflammatory cells play in cancer according to Dr. Egeblad?

Inflammatory cells can play a dual role in cancer. They are crucial in defending against infections and aiding wound healing, but tumors can hijack these processes to promote growth and metastasis. Dr. Egeblad's research explores how these cells can be manipulated to target and destroy cancer cells instead.

Q: What innovative techniques are used in Dr. Egeblad's research?

The research utilizes innovative imaging techniques that involve fluorescent labeling of cells to observe their interactions in real-time. This allows researchers to see how immune cells and cancer cells interact within live tissue, providing insights into the effectiveness of treatments and the behavior of tumors.

Q: What potential solutions does Dr. Egeblad propose for improving cancer treatment?

Dr. Egeblad proposes manipulating immune cell behavior to enhance the effectiveness of existing cancer treatments. By redirecting inflammatory cells to target cancer cells, and improving drug delivery to all tumor areas, her research aims to improve treatment outcomes and potentially prevent tumor growth and metastasis.

Q: Why is basic research important in cancer treatment development?

Basic research is crucial as it provides foundational knowledge and unexpected insights that can lead to breakthroughs in cancer treatment. Dr. Egeblad's work highlights how discoveries in unrelated fields, like marine biology, can be applied to cancer research, leading to innovative approaches and improved therapies.

Q: How does community support impact Dr. Egeblad's research?

Community support plays a significant role in Dr. Egeblad's research by providing essential funding that enables her team to pursue innovative projects and secure further federal funding. Local donations, regardless of size, contribute to advancing research efforts and developing new treatment strategies for breast cancer.

Summary & Key Takeaways

• Cold Spring Harbor Laboratory is a renowned cancer research institution, with over half of its research focused on cancer, including breast cancer. Dr. Mikala Egeblad's work at the laboratory involves using imaging techniques to study the interaction between the immune system and breast cancer tumors.

• Dr. Egeblad's research has revealed challenges in drug delivery to tumors, with some areas not receiving adequate drug concentrations. Her work also explores the role of inflammatory cells in cancer, which can either aid tumor growth or be manipulated to target cancer cells.

• The research employs innovative imaging techniques, using fluorescent labeling to observe live interactions between cancer cells and immune cells in mice. Dr. Egeblad emphasizes the importance of basic research and community support in advancing cancer research and aims to harness immune cells' ability to destroy cancer cells.